insights_auto
Why is ORX up 4.00%?
Dive Deeperchevron_right
ORX:STO
Orexo AB
SEKÂ 0.88
arrow_upward
+4.00%(+0.034) 1D
Nov 17, 2:26:22 PM GMT+1 · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ORX...
Open
SEKÂ 0.83
High
SEKÂ 0.98
Low
SEKÂ 0.83
Mkt. cap
309.46M
Avg. vol.
790.03K
Volume
609.16K
P/E ratio
0.06
52-wk high
SEKÂ 22.55
52-wk low
SEKÂ 0.80
EPS
SEKÂ 13.61
Shares outstanding
35.13M
No. of employees
55
Open
SEKÂ 0.83
High
SEKÂ 0.98
Low
SEKÂ 0.83
Mkt. cap
309.46M
Avg. vol.
790.03K
Volume
609.16K
P/E ratio
0.06
52-wk high
SEKÂ 22.55
52-wk low
SEKÂ 0.80
EPS
SEKÂ 13.61
Shares outstanding
35.13M
No. of employees
55
News stories
From web sources and news partners
FOREX.com
·
26 minutes ago
S&P 500 forecast: Why US stocks have largely defied gravity and what could trigger a correction
Quartz
·
45 minutes ago
The Dow fell more than 700 points on Monday and the S&P 500 lost 1.9%
Investor's Business Daily
·
36 minutes ago
Analysts Expect 4 S&P 500 Stocks To Outgrow Nvidia Next Year
Profile
Orexo is a Swedish pharmaceutical company that develops improved pharmaceuticals based on innovative formulation technologies that meet large medical needs. Through presence its in the US market, drugs and digital therapies are commercialized to treat opioid use disorder and adjacent diseases. Products targeting other therapeutic areas are developed and commercialized worldwide with partners. Wikipedia
About Orexo AB
CEONikolaj Sørensen
Employees55
Founded1995
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websiteorexo.com